Guy Scadding. (2022). Real world evidence of long-term benefits from allergen-specific immunotherapy (AIT). Elsevier.
Chicago Style (17th ed.) CitationGuy Scadding. Real World Evidence of Long-term Benefits from Allergen-specific Immunotherapy (AIT). Elsevier, 2022.
MLA (9th ed.) CitationGuy Scadding. Real World Evidence of Long-term Benefits from Allergen-specific Immunotherapy (AIT). Elsevier, 2022.
Warning: These citations may not always be 100% accurate.